For nearly 11,000 years, humans have found innovative and ground-breaking ways to improve the health and well-being of animals in their lives. In 9000 B.C., sheepherders in many countries of the Middle East used their medical skills and knowledge to treat their dogs and livestock. The Babylonians’ in 2500 B.C. established the first recorded measures for rabies control. In fact in the last 1800s, Dr. Rudolf Virchow, a German Pathologist, stated, “Between animal and human medicines there are no dividing lines- nor should there be. The object is different but the experience obtained constitutes the basis of all medicine.”
Creating the best medicines and molecules to improve the health and well-being of animals comes from a variety of scientific innovations. One of the strengths of being a part of a life-science company like Bayer, means that research done in both human health and plant health, can be translated into animal health through collaboration and strong partnerships.
Our vision is simple yet very solid. We want to be the customer’s first choice for animal health and well-being, and we know that partnerships give us the opportunity to combine the innovation generated by potential likeminded partners with our comprehensive scientific, manufacturing and commercial expertise and capabilities, all for the benefit of animals. Because we truly believe that healthy animals make the world a better place.
While aiming for flexible and innovative deal structures, our partnering philosophy is focused on building long term partnering relations across the globe both in the areas of Farm Animals and Companion Animals. Our recent partnership announcements with Mitsui Chemicals Agro, NeuroCycle Therapeutics, PTT and just recently, adivo are exciting, because they give us access to new scientific areas, molecules or know-how and therefore have the potential to impact shape our business going forward.
When it comes to finding innovative partnerships in the areas of farm animals, Bayer focuses on early and late-stage assets and technologies in parasite control, fertility enhancement, antibiotic alternatives, metabolic health, and much more. On the companion animal side, we look for new ways to reduce inflammation, allergies, and pain, combat cardiovascular and renal disease, and improve the quality of life of aging pets.
This year, I was welcomed as an expert speaker at the Animal Health Investment Forum which showcases clear examples of why investing in this industry is a smart decision. Whether it is a start-up company or a multi-national corporation, new innovations, technologies, and partnerships make Animal Health an industry worth being in for another 11,000 years.
To learn more about our partnership philosophy, visit animalhealth.bayer.com/partnering.